Results 101 to 110 of about 172,168 (267)
Gramicidin Inhibits Lung Cancer Metastasis by Suppressing the ABL‐MMP9 Signaling Axis
Gramicidin inhibits ABL expression in lung cancer cells, promoting the downregulation of MMP9 expression. Blockade of the ABL–MMP9 signaling axis attenuates the migration and invasion capacity of cancer cells, ultimately suppressing lung metastasis. ABSTRACT Lung cancer, the deadliest malignant tumor worldwide, consists predominantly of non‐small cell ...
Xiuying Li, Ling Chen
wiley +1 more source
BACKGROUND AND OBJECTIVES: We previously described a novel type of the chimeric bcr-abl mRNA transcript in a patient with a Philadelphia chromosome positive chronic myeloid leukemia. A similar bcr-abl transcript has also been described by others.
G Martinelli +8 more
doaj
Interactions of p62(dok) with p210(bcr-abl) and Bcr-Abl-associated proteins.
A 62-kDa Ras GTPase-activating protein (RasGAP)-associated protein is tyrosine-phosphorylated under a variety of circumstances including growth factor stimulation and in cells transformed by activated tyrosine kinases. A cDNA for p62(dok), reported to be the RasGAP-associated 62-kDa protein, was recently cloned from Abl-transformed cells. In this study,
A, Bhat +4 more
openaire +2 more sources
Cytoreductive therapy reduces JAK2V617F+ blood velocity and adhesion to activated endothelium
British Journal of Haematology, EarlyView.
Angelica DaSilva +8 more
wiley +1 more source
Protein Lactylation in Cancer: From Mechanisms to Therapy
Increased glycolysis and lactate accumulation promote histone and nonhistone protein lactylation, linking tumor metabolic reprogramming to treatment adaptation. Lactylation enhances DNA repair, suppresses antitumor immunity, strengthens antioxidant defenses, and facilitates cell‐cycle checkpoint escape, collectively promoting resistance to chemotherapy,
Wentian Huang +8 more
wiley +1 more source
Figure S3. BCR-ABL reduces ISG expression in 32D cells. Gene expression microarray analysis of 32D-EV, 32D-BCR-ABL, or 32D-JAK2V617F cells. Fold change of gene expression is shown, depicting downregulation of the analyzed gene in blue and upregulation in
Manuel Allhoff (6548633) +11 more
core +1 more source
DETECTION OF BCR-ABL PROTEIN IN CHRONIC MYELOID LEUKEMIA PATIENTS USING IMMUNOCYTOCHEMISTRY
Background: Chronic Myeloid leukemia (CML) is a myeloproliferetive disorder associated with chromosomal abnormality, Philadelphia chromosome (Ph), in more than 95% of CML patients. The resulting BCR-ABL fused gene is markers for this type of leukemia. In
Maysaa Abdul Razaq Dhahi +2 more
doaj +6 more sources
Objective: The BCR-ABL(IS) value plays a crucial role in the prognosis of chronic myeloid leukemia (CML) patients. The aim of this study was to compare molecular response rates two BCR-ABL(IS) score levels at the time of diagnosis in chronic-phase CML ...
Vehbi Demircan +3 more
doaj +1 more source
Our previous study showed that besides mRNAs and microRNAs, there are DNA fragments within extracellular vesicles (EVs). The BCR/ABL hybrid gene, involved in the pathogenesis of chronic myeloid leukemia (CML), could be transferred from K562 EVs to ...
Jin Cai +13 more
semanticscholar +1 more source
Quantitative Assessment of the BCR-ABL Transcript Using the Cepheid Xpert BCR-ABL Monitor Assay
Abstract Context. —Chronic myelogenous leukemia (CML) and the assessment of the BCR-ABL transcript has become a new paradigm. Novel tyrosine kinase inhibitors as mainstream therapeutic options for the CML patient warrant routine quantification of the
Scott D, Dufresne +3 more
openaire +2 more sources

